WhatsApp
backNews Article

Genesys International Posts Rs. 7,779.81 Lakh Revenue and Rs. 528.88 Lakh Profit in Q2 2026; Grants 3.65 Lakh Employee Stock Options

Board approves unaudited standalone financials for quarter ended September 30, 2026 and ESOP grants at 48.43%-63.90% discount to market price

Genesys International Corporation Limited announced its unaudited standalone financial results for the quarter ended September 30, 2026, reporting revenue from operations of Rs. 7,779.81 lakh and profit after tax of Rs. 528.88 lakh. The company also granted 3,65,000 employee stock options at discounted exercise prices between Rs.70 and Rs.100 per share under its 2022 Employee Stock Option Scheme.

2 days ago|GENESYS+0.00%
Genesys International Corporation LimitedBSE:506109NSE:GENESYSInvestor Presentation

Genesys International Corporation Limited

Investor Presentation

Genesys International Corporation Limited reported its unaudited standalone financial results for the quarter ended September 30, 2026, with revenue from operations totaling Rs. 7,779.81 lakh and net profit of Rs. 528.88 lakh. Additionally, the company granted 3,65,000 employee stock options under its 2022 ESOP scheme at exercise prices discounted significantly to recent market prices.

Total income for the quarter reached Rs. 8,001.10 lakh, comprising Rs. 7,779.81 lakh from operations and Rs. 221.29 lakh from other income.

Total expenses for the quarter were Rs. 7,273.26 lakh including project expenses of Rs. 3,875.34 lakh and employee benefits expenses of Rs. 1,290.78 lakh.

Profit before tax stood at Rs. 727.84 lakh, with tax expenses totaling Rs. 198.96 lakh resulting in a net profit of Rs. 528.88 lakh for Q2 2026.

The company reported a total comprehensive income of Rs. 586.60 lakh for the quarter, which includes other comprehensive income related to defined benefit plan remeasurements.

The board approved the grant of 3,65,000 employee stock options to eligible employees under the Genesys Employee Stock Option Scheme 2022, including 4,640 options re-granted from previously lapsed ones, with exercise prices ranging from Rs. 70 to Rs. 100 per equity share, representing a discount between 48.43% and 63.90% to the closing price on November 12, 2026.

Highlights

  • Q2 2026 revenue from operations: Rs. 7,779.81 lakh
  • Profit after tax for Q2 2026: Rs. 528.88 lakh
  • Total comprehensive income: Rs. 586.60 lakh
  • 3,65,000 employee stock options granted
  • ESOP exercise price between Rs. 70 and Rs. 100 per share
  • Discount of 48.43%-63.90% to NSE closing price on Nov 12, 2026

Key Data Snapshot

Quarter endedSeptember 30, 2026
Revenue from operationsRs. 7,779.81 lakh
Profit after taxRs. 528.88 lakh
Total comprehensive incomeRs. 586.60 lakh
Employee stock options granted3,65,000 options
ESOP exercise price rangeRs. 70 to Rs. 100 per equity share
ESOP discount to closing price on NSE48.43% to 63.90%
Stock exchangesBSE: 506109, NSE: GENESYS

What happened

  • The Board of Directors approved the unaudited standalone financial results for the quarter ended September 30, 2026.
  • Revenue from operations totaled Rs. 7,779.81 lakh for the quarter.
  • Profit after tax for the quarter was Rs. 528.88 lakh.
  • Comprehensive income, including other comprehensive income, was Rs. 586.60 lakh.
  • Board approved the grant of 3,65,000 employee stock options under the 2022 ESOP scheme.

Key details

  • Total income for the quarter was Rs. 8,001.10 lakh, including Rs. 221.29 lakh of other income.
  • Total expenses amounted to Rs. 7,273.26 lakh, including project expenses of Rs. 3,875.34 lakh and employee benefit expenses of Rs. 1,290.78 lakh.
  • Tax expenses for the quarter were Rs. 198.96 lakh, consisting of current and deferred tax.
  • Employee stock options granted included 4,640 options re-granted from lapsed ones.
  • ESOP exercise prices ranged from Rs. 70 to Rs. 100 per equity share reflecting a discount to the closing share price on November 12, 2026.

Regulatory and governance context

  • Financial results were prepared in accordance with Indian Accounting Standards (Ind AS).
  • Results were reviewed by statutory auditors and reviewed by the Audit Committee before board approval.
  • ESOP grant complies with the company's 2022 Employee Stock Option Scheme and SEBI regulations.
  • Disclosure made in compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

More News on Investor Presentation

View all

Latest corporate announcements and market updates in Investor Presentation.

View all news
Genesys International Posts Rs. 7,779.81 Lakh Revenue | Stockk News